Thu, January 19, 2023
Wed, January 18, 2023
Tue, January 17, 2023
Mon, January 16, 2023
Sat, January 14, 2023
Fri, January 13, 2023
Thu, January 12, 2023

David Risinger Upgraded (VRTX) to Buy and Increased Target to $374 on, Jan 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. nd-increased-target-to-374-on-jan-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Risinger of SVB Leerink, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy and Increased Target from $265 to $374 on, Jan 17th, 2023.

David has made no other calls on VRTX in the last 4 months.



There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Held Target at $340 on, Monday, December 19th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $301 on, Tuesday, November 15th, 2022
  • Brian Skorney of "Baird" Maintained at Hold and Held Target at $280 on, Monday, October 31st, 2022
  • Paul Matteis of "Stifel" Maintained at Hold and Held Target at $289 on, Sunday, October 30th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $285 on, Friday, October 28th, 2022


These are the ratings of the 8 analyists that currently disagree with David


  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $340 on, Thursday, November 17th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $350 on, Friday, November 11th, 2022
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $442 on, Monday, October 31st, 2022
  • Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $330 on, Friday, October 28th, 2022
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $313 on, Friday, October 28th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $335 on, Friday, October 28th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $327 on, Monday, October 24th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $337 on, Friday, October 21st, 2022

Publication Contributing Sources